Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

pancreatic ductal adenocarcinoma

  • Open Access
    Contribution of Immunoscore to Survival Prediction in Pancreatic Ductal Adenocarcinoma
    HARUKI MORI, TORU MIYAKE, HIROMITSU MAEHIRA, MASANORI SHIOHARA, HIROYA IIDA, NOBUHITO NITTA and MASAJI TANI
    Anticancer Research October 2024, 44 (10) 4483-4492; DOI: https://doi.org/10.21873/anticanres.17277
  • You have access
    A Comparative Analysis of ARX and ANFIS Models for Tumor Growth Prediction Under Single and Multi-agent Chemotherapy
    SOTIRIOS G. LILIOPOULOS, GEORGE S. STAVRAKAKIS and KONSTANTINOS S. DIMAS
    Anticancer Research June 2024, 44 (6) 2425-2436; DOI: https://doi.org/10.21873/anticanres.17049
  • You have access
    Clinical Significance of Phosphorylated Sphingosine Kinase 1 Expression in Pancreatic Ductal Adenocarcinoma
    HIROKI NAGARO, HIROSHI ICHIKAWA, KAZUYASU TAKIZAWA, MASAYUKI NAGAHASHI, SHUN ABE, YUKI HIROSE, KAZUKI MORO, KOHEI MIURA, MASATO NAKANO, YOSHIFUMI SHIMADA, JUN SAKATA and TOSHIFUMI WAKAI
    Anticancer Research September 2023, 43 (9) 3969-3977; DOI: https://doi.org/10.21873/anticanres.16584
  • Open Access
    Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic Cancer Cells
    DAISUKE TATSUDA, JUNJIRO YOSHIDA, TOMOKAZU OHISHI and MANABU KAWADA
    Anticancer Research June 2023, 43 (6) 2477-2489; DOI: https://doi.org/10.21873/anticanres.16415
  • Open Access
    Prophylactic Anticoagulation in Patients With Pancreatic Adenocarcinoma: A Single Tertiary Care Center Retrospective QI Project
    SHIVANI SHAH, CHELSEA PETERSON, JIAXIANG LIU and DULABH K. MONGA
    Anticancer Research January 2023, 43 (1) 137-141; DOI: https://doi.org/10.21873/anticanres.16142
  • Open Access
    D1 Distal Pancreatectomy for Left-sided Pancreatic Ductal Adenocarcinoma Is Justifiable: A Propensity-score Matched Multicenter Study
    TARO SAKAMOTO, TAKESHI GOCHO, MASASHI TSUNEMATSU, YOSHIHIRO SHIRAI, RYOGA HAMURA, KOICHIRO HARUKI, KYOHEI ABE, TOMOYOSHI OKAMOTO, HIRONORI SHIOZAKI, SHUICHI FUJIOKA, RYOTA IWASE, YU KUMAGAI, TERUYUKI USUBA and TORU IKEGAMI
    Anticancer Research January 2023, 43 (1) 201-208; DOI: https://doi.org/10.21873/anticanres.16150
  • You have access
    Intracellular C3 Modulates EMT via the Akt/Smad Pathway in Pancreatic Cancer Cells
    REI SUZUKI, TADAYUKI TAKAGI, MITSURU SUGIMOTO, YUKI SATO, HIROKI IRIE, YUKI YOMOGIDA and HIROMASA OHIRA
    Anticancer Research December 2022, 42 (12) 5743-5750; DOI: https://doi.org/10.21873/anticanres.16081
  • You have access
    Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma
    YOSHIKI NAITO, JUN AKIBA, YOSHINAO KINJO, EIJI SADASHIMA, TOSHIRO OGATA, YUTA YANO, MASAHIKO TANIGAWA, MASAMICHI NAKAYAMA, AKIHIKO KAWAHARA, YOSHINOBU OKABE, HISAMUNE SAKAI, TORU HISAKA, YOSHITO AKAGI and HIROHISA YANO
    Anticancer Research August 2022, 42 (8) 4145-4151; DOI: https://doi.org/10.21873/anticanres.15913
  • Open Access
    The Effects of Treatment on Peripheral Blood Immune Cell Profile in Pancreatic Ductal Adenocarcinoma (PDAC)
    SKAISTE TULYTE, DAINIUS CHARACIEJUS, REDA MATUZEVICIENE, AUSRA JANIULIONIENE, MANTAS RADZEVICIUS, TADAS ZVIRBLIS and AUDRIUS SILEIKIS
    Anticancer Research June 2022, 42 (6) 3067-3073; DOI: https://doi.org/10.21873/anticanres.15794
  • You have access
    Prognostic Impact of Relative Dose Intensity of Adjuvant Chemotherapy With S-1 on Pancreatic Ductal Adenocarcinoma
    HAJIME MATSUSHIMA, TOMOHIKO ADACHI, MASAAKI HIDAKA, MAMPEI YAMASHITA, TAKASHI HAMADA, SAEKO FUKUI, TAKAYUKI TANAKA, HAJIME IMAMURA, KYOHEI YOSHINO, TOTA KUGIYAMA, AMANE KITASATO, TAKANOBU HARA, AKIHIKO SOYAMA, KAZUMA KOBAYASHI, YORIHISA SUMIDA, TAMOTSU KUROKI and SUSUMU EGUCHI
    Anticancer Research June 2022, 42 (6) 3133-3141; DOI: https://doi.org/10.21873/anticanres.15802

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire